The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials ; volume:27 ; number:1 ; day:20 ; month:1 ; year:2023 ; pages:1-11 ; date:12.2023
Critical care ; 27, Heft 1 (20.1.2023), 1-11, 12.2023
- Creator
-
Wang, Fengyun
Li, Yiming
Wang, Bingqing
Li, Jianguo
Peng, Zhiyong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-022-04287-4
- URN
-
urn:nbn:de:101:1-2023032821335485251618
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Fengyun
- Li, Yiming
- Wang, Bingqing
- Li, Jianguo
- Peng, Zhiyong
- SpringerLink (Online service)
Other Objects (12)
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs
Mesenchymal stromal cells for osteonecrosis
Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
Mesenchymal stromal cells as cancer promoters
Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?
Umbilical cord mesenchymal stromal cells in serum-free defined medium display an improved safety profile
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs
Mesenchymal stromal cells for osteonecrosis
Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
Mesenchymal stromal cells as cancer promoters
Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?
Umbilical cord mesenchymal stromal cells in serum-free defined medium display an improved safety profile
Mesenchymal stromal/stem cell (MSC)-derived exosomes in clinical trials
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs
Mesenchymal stromal cells for osteonecrosis
Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials
Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients
In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial
Mesenchymal stromal cells as cancer promoters
Clinical Trials Based on Mesenchymal Stromal Cells are Exponentially Increasing: Where are We in Recent Years?